Only in Titles

Search results for: Esophagus

paperclip

#33098338   2020/10/24 To Up

Prognostic Impact of Metastatic Site and Pattern in Patients with Metastatic Head and Neck Cancer.

Investigate the relationship between site and pattern of distant metastasis (DM) and overall survival (OS) in a multi-institutional cohort of patients with DM head and neck cancer (HNC).
Craig A Bollig, Christopher I Newberry, Tabitha L I Galloway, Robert P Zitsch, Elyse K Hanly, Vivian L Zhu, Nitin Pagedar, Rohit Nallani, Andres M Bur, William C Spanos, Jeffrey B Jorgensen

2608 related Products with: Prognostic Impact of Metastatic Site and Pattern in Patients with Metastatic Head and Neck Cancer.



Related Pathways

paperclip

#33098035   2020/10/23 To Up

The "caterpillar sign": a novel endoscopic indicator of eosinophilic esophagitis.

Although several endoscopic findings of eosinophilic esophagitis (EoE), such as the EoE endoscopic reference score (EREFS), have been reported thus far, these endoscopic findings exhibit low specificity. Furthermore, most of these endoscopic findings were evaluated solely in patients from Western nations. We have recently noted a fragile, protruded mucosal lesion sandwiched between longitudinal furrows (similar to caterpillar tracks) on the esophagus in patients with EoE. We have termed this novel finding the "caterpillar sign". This study evaluated the clinical significance of the caterpillar sign and the EREFS for diagnosis of EoE in Japanese patients.
Maki Ayaki, Noriaki Manabe, Jun Nakamura, Minoru Fujita, Tomoari Kamada, Kazumi Imamura, Kazuhiko Inoue, Ken Haruma

1912 related Products with: The "caterpillar sign": a novel endoscopic indicator of eosinophilic esophagitis.

100.00 ul50ul100 ug0.1 mg100 100 ml.

Related Pathways

    No related Items
paperclip

#33097772   2020/10/23 To Up

The endoluminal pressures during flexible gastrointestinal endoscopy.

In flexible gastrointestinal (GI) endoscopy, endoscopic insufflation is crucial and directly affects visualization. Optimal visualization enables endoscopists to conduct better examinations and administer optimal treatments. However, endoscopic insufflation is typically performed manually and is subjective. We aimed to measure the GI endoluminal pressure during flexible GI endoscopy. Participants underwent esophagogastroduodenoscopy (EGD) at our endoscopy center. Pressure measurement was conducted after completing diagnostic or follow-up EGD. The endoluminal pressure in the esophagus and stomach was measured at 1-s intervals for 1 min while performing EGD for observational and diagnostic purposes. During the measurements, the endoscopists maintained what they subjectively considered to be adequate exposure for screening for lesions by dilating the lumen. Eighty patients were enrolled in this study. The upper GI endoluminal pressure was assessed during EGD without adverse events. The esophageal endoluminal pressure averaged 8.9 (- 3.0 to 20.7) mmHg, and the gastric endoluminal pressure averaged 10.0 (3.0-17.9) mmHg; the upper GI endoluminal pressures were not affected by patient-related factors or the number of endoscopists' postgraduate years. We have successfully obtained the GI endoluminal pressures during EGD. Further accumulation of these data may lead to more stable and reproducible flexible endoscopic diagnosis and intervention.
Yuki Ushimaru, Kiyokazu Nakajima, Masashi Hirota, Yasuaki Miyazaki, Kotaro Yamashita, Takuro Saito, Koji Tanaka, Tomoki Makino, Tsuyoshi Takahashi, Yukinori Kurokawa, Makoto Yamasaki, Masaki Mori, Yuichiro Doki

1823 related Products with: The endoluminal pressures during flexible gastrointestinal endoscopy.

96T 100ul1 mg100 U100.00 ul1 kit(96 Wells)200 units100 100 G1

Related Pathways

paperclip

Error loading info... Pleas try again later.
paperclip

#33094604   // To Up

Ringed esophagus sign on barium esophagogastroduodenoscopy.


A J Láinez Ramos-Bossini, M J Hernández-Abad, R M Malo-Prian

2907 related Products with: Ringed esophagus sign on barium esophagogastroduodenoscopy.

30 Pcs Per Pack3 Pcs Per PackKIT220 Pcs Per Pack 25 ml Ready-to-use 30 Pcs Per Pack50ul30 Pcs Per Pack2 Pieces/Box2 5 Pcs Per Pack

Related Pathways

    No related Items
paperclip

#33094601   // To Up

Choledochoscope-assisted antegrade-retrograde endoscopic dilation of complete esophageal stenosis in a patient with dystrophic epidermolysis bullosa.

Dystrophic epidermolysis bullosa is a mucocutaneous disorder, characterized by recurrent formation of blisters and scarring. The gastrointestinal tract is commonly affected by the disease and the proximal esophagus is the most common area of involvement of the gastrointestinal tract. The esophageal strictures are common in patients with dystrophic epidermolysis bullosa that can lead to complete esophageal stenosis in some cases. The antegrade/retrograde endoscopic dilation is a commonly used method in these patients. Different kinds of endoscopes may be used for the retrograde procedure, such as conventional upper gastrointestinal (UGI) endoscopes, slim-paediatric UGI endoscopes and ultrathin UGI nasal endoscopes. Herein, we reported the first antegrade/retrograde esophageal dilation case performed under choledochoscopic guidance.
H Koklu, C Vahabov, E Parlak, T Kav

1205 related Products with: Choledochoscope-assisted antegrade-retrograde endoscopic dilation of complete esophageal stenosis in a patient with dystrophic epidermolysis bullosa.



Related Pathways

paperclip

#33094451   2020/10/23 To Up

Risk of Progression of Gastric Intestinal Metaplasia Is Significantly Greater When Detected in Both Antrum and Body.

Gastric cancer (GC) is the fifth leading cause of cancer-related death worldwide. GC is usually preceded by a cascade of well-defined precursor lesions, set in place by an environmental trigger (H. pylori) including intestinal metaplasia (GIM) and dysplasia.
Anthony O'Connor, Adam Bowden, Eoin Farrell, Joshua Weininger, Stephen Crowther, Deirdre McNamara, Paul Ridgway, Colm O'Morain

2910 related Products with: Risk of Progression of Gastric Intestinal Metaplasia Is Significantly Greater When Detected in Both Antrum and Body.

100ug Lyophilized100ug Lyophilized100ug Lyophilized100ug Lyophilized100ug Lyophilized100ug Lyophilized100ug Lyophilized100ug100ug Lyophilized100ug Lyophilized

Related Pathways

paperclip

#33093162   2020/10/22 To Up

Barretts Esophagus and Esophageal Adenocarcinoma Biomarkers.

Esophageal adenocarcinoma (EAC) is a major cause of cancer related morbidity and mortality in Western countries. The incidences of EAC and its precursor Barrett's esophagus (BE) have increased substantially in the last four decades. Current care guidelines recommend that endoscopy be used for the early detection and monitoring of patients with BE, however, the efficacy of this approach is unclear. In order to prevent the increasing morbidity and mortality from EAC, there is a need for early detection and surveillance biomarker assays that are accurate, low-cost, and clinically feasible to implement. The last decade has seen remarkable advances in the development of minimally invasive molecular biomarkers, an effort led in large part by the Early Detection Research Network (EDRN). Advances in multi-omics analysis, the development of swallowable cytology collection devices, and emerging technology have led to promising assays that are likely to be implemented into clinical care in the next decade, with the most promising markers to date being methylated VIM and CCNA1. In this review, an updated overview of the molecular pathology of BE and EAC and emerging molecular biomarker assays, as well as the role of EDRN in biomarker discovery and validation, will be discussed.
William M Grady, Ming Yu, Sanford D Markowitz, Amitabh Chak

1054 related Products with: Barretts Esophagus and Esophageal Adenocarcinoma Biomarkers.

10 mg1000 tests2.5 mg

Related Pathways

paperclip

#33093060   2020/10/22 To Up

Diagnosis of oesophageal mucormycosis managed with medical therapy alone.

Mucormycosis is an invasive mould that can cause aggressive infection, particularly in immunocompromised patients. Though oesophageal mucormycosis is relatively rare, it remains an elusive and devastating manifestation of this disease. The management is also challenging, due to surgical morbidity and contraindications such as thrombocytopenia in immunocompromised hosts. In this report, we present the case of a 60-year-old Lebanese man with newly diagnosed acute myeloid leukaemia who developed oesophageal mucormycosis after induction chemotherapy with idarubicin/cytarabine (7+3). The diagnosis was made when the patient developed febrile neutropenia and odynophagia. CT scan of the chest revealed a thickened oesophagus. Oesophagogastroduodenoscopy with biopsy, histopathology and PCR were performed, resulting in the diagnosis of The patient was successfully treated with liposomal amphotericin B and salvage posaconazole therapy without surgical intervention. We reviewed the clinical characteristics of the six published oesophageal mucormycosis reports from the literature.
Matthew Ringer, Lauren Pischel, Marwan Mikheal Azar

2609 related Products with: Diagnosis of oesophageal mucormycosis managed with medical therapy alone.

5 G

Related Pathways

paperclip

Error loading info... Pleas try again later.